<--- Back to Details
First PageDocument Content
Health / Pharmacology / Pharmaceutical industry / Pharmaceuticals policy / Labels / Federal Department of Home Affairs / Swissmedic / European Directorate for the Quality of Medicines / Packaging and labeling / Marketing authorization / Tablet / Dosage form
Health
Pharmacology
Pharmaceutical industry
Pharmaceuticals policy
Labels
Federal Department of Home Affairs
Swissmedic
European Directorate for the Quality of Medicines
Packaging and labeling
Marketing authorization
Tablet
Dosage form

ZL000_00_021e_WL Guidance document Packaging for human medicinal products HMV4

Add to Reading List

Source URL: www.swissmedic.ch

Download Document from Source Website

File Size: 594,33 KB

Share Document on Facebook

Similar Documents

MU103_10_002e_WL Guidance document Information of PSUR PBRER submission HMV 4

MU103_10_002e_WL Guidance document Information of PSUR PBRER submission HMV 4

DocID: 1xVBP - View Document

ZL000_00_032e_WL Guidance document Authorisation of allergen product HMV4

ZL000_00_032e_WL Guidance document Authorisation of allergen product HMV4

DocID: 1xVwb - View Document

Pip / Swissmedic

16256000Basic information Name of medicinal product: …… Authorisation no: …… If known Application ID: …… If known

DocID: 1xUPG - View Document

ZL000_00_021e_WL Guidance document Packaging for human medicinal products HMV4

ZL000_00_021e_WL Guidance document Packaging for human medicinal products HMV4

DocID: 1xUPn - View Document

ZL103_00_003e_WL Guidance document Authorisation of individual teas, cough and throat lozenges and pastilles in the notification procedure HMV4

ZL103_00_003e_WL Guidance document Authorisation of individual teas, cough and throat lozenges and pastilles in the notification procedure HMV4

DocID: 1xU0C - View Document